Sunshine Biopharma Inc (SBFM)
0.84
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.854
+0.01
(+1.67%)
After-Hours: 20:00
Sunshine Biopharma Cash from Operations (Quarterly): -2.690M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.690M |
| September 30, 2023 | -0.4573M |
| June 30, 2023 | -3.778M |
| March 31, 2023 | -1.850M |
| December 31, 2022 | -2.247M |
| September 30, 2022 | -1.124M |
| June 30, 2022 | -0.5738M |
| March 31, 2022 | -1.304M |
| December 31, 2021 | -0.3121M |
| September 30, 2021 | -0.6008M |
| June 30, 2021 | -0.6189M |
| March 31, 2021 | -0.2974M |
| December 31, 2020 | -0.4237M |
| September 30, 2020 | -0.1206M |
| June 30, 2020 | -0.082M |
| March 31, 2020 | -0.031M |
| December 31, 2019 | -0.1278M |
| September 30, 2019 | -0.0865M |
| June 30, 2019 | -0.0475M |
| March 31, 2019 | -0.234M |
| December 31, 2018 | -0.116M |
| September 30, 2018 | -0.1709M |
| June 30, 2018 | -0.0574M |
| March 31, 2018 | -0.1685M |
| December 31, 2017 | -0.2095M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.1482M |
| June 30, 2017 | -0.0778M |
| March 31, 2017 | -0.108M |
| December 31, 2016 | -0.0312M |
| September 30, 2016 | -0.063M |
| June 30, 2016 | -0.1384M |
| March 31, 2016 | -0.0816M |
| December 31, 2015 | -0.3428M |
| September 30, 2015 | -0.1026M |
| June 30, 2015 | -0.3092M |
| March 31, 2015 | -0.113M |
| December 31, 2014 | -0.2477M |
| September 30, 2014 | -0.0181M |
| June 30, 2014 | -0.182M |
| March 31, 2014 | -0.0908M |
| December 31, 2013 | -0.0397M |
| September 30, 2013 | -0.0856M |
| June 30, 2013 | -0.0993M |
| March 31, 2013 | -0.3397M |
| December 31, 2012 | -0.1728M |
| September 30, 2012 | -0.1603M |
| June 30, 2012 | -0.0252M |
| March 31, 2012 | -0.0348M |
| December 31, 2011 | -0.1178M |
| September 30, 2011 | -0.1184M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.778M
Minimum
Jun 2023
-0.031M
Maximum
Mar 2020
-0.8827M
Average
-0.4573M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| Lexaria Bioscience Corp | -0.6196M |
| Acasti Pharma Inc | -1.892M |
| Aurinia Pharmaceuticals Inc | 14.31M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -35.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.2692M |
| Cash from Financing (Quarterly) | -0.0305M |
| Free Cash Flow | -9.563M |
| Free Cash Flow Per Share (Quarterly) | -12.57 |
| Free Cash Flow to Equity (Quarterly) | -2.993M |
| Free Cash Flow to Firm (Quarterly) | -2.993M |
| Free Cash Flow Yield | -4.70K% |